# clm_B82BAA2538E3

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 667,434,000 United States dollar  
valid_from: 2020-09-30  
valid_to: 2021-03-31  
published: 2020-10-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D8AA2809B20A  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly net income: 667,434,000 United States dollar", as of 2020-09-30 (until 2021-03-31). Claim clm_B82BAA2538E3, https://asof.is/claim/clm_B82BAA2538E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532020000043/0000875320-20-000043-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-10-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532020000043/0000875320-20-000043-index.htm (primary, SEC EDGAR 10-Q Q3 FY2020, published 2020-10-30)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_net_income | 837,270,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_B82BAA2538E3](/claim/clm_B82BAA2538E3.md) | [clm_CBAB0AE654C4](/claim/clm_CBAB0AE654C4.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.